You are here: Home » Current Affairs » Coronavirus » News
Maharashtra curfew: Half of factories may remain shut for next fortnight
Great Learning focuses on job readiness of students, looks to raise $60 mn
Business Standard

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Topics
Coronavirus Vaccine | Bharat Biotech | Vaccine

Sohini Das  |  Mumbai 



Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma
Bharat Biotech is using Kansas-based ViroVax’s adjuvant to boost the immune response to its Covaxin

With Hyderabad-based maker in the midst of ramping up its capacity for Covaxin, sources said the biotechnology company is facing challenges in procuring the adjuvant used in the .

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Thu, April 15 2021. 02:16 IST

RECOMMENDED FOR YOU